NPO Petrovax Pharm will supply Grippol vaccine to Kazakhstan

| By | Export of Medicines, Petrovax, Vaccines

NPO Petrovax Pharm began to export a flu-prevention vaccine to Kazakhstan. More than 2 million doses of Grippol® Plus will be supplied to the country this August. The supplies will cover basic needs of Kazakhstan’s population in vaccination during the epidemiological season of 2017-2018.

To immunize the population, the vaccine will be available as early as in September 2017, at the beginning of the epidemiological season. The categories of Kazakhstan’s population that are subject to mandatory vaccination against flu, including children aged six months and older, pregnant women, healthcare professionals, and persons over 60 years old, will be vaccinated as part of the free medical care.

NPO Petrovax Pharm exports the vaccine against flu to Kazakhstan since 2016 in partnership with KPC Medservice Plus LLP, the leading distributor in the pharmaceutical market of the Republic of Kazakhstan. Within the two years, the total supplies to Kazakhstan amounted to more than 3.6 million doses. KPC Medservice Plus LLP is a partner of NPO Petrovax Pharm for more than 5 years and, during this time, the companies implemented several successful projects.

Since 2015, the company has been an active participant of specialized scientific congresses in Kazakhstan. In August and September 2017, NPO Petrovax Pharm will take part in scientific and practical conferences of Kazakhstan on prevention of flu and focusing on other relevant infectious diseases in Central Asia.

GMP news
Pharmaceutical industry News and events. Technology transfer and contract manufacturing of medicines.